New Zealand markets closed

ABBV Jan 2023 80.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.55000.0000 (0.00%)
As of 03:04PM EDT. Market open.
Full screen
Previous close0.5500
Open0.5600
Bid0.0000
Ask0.0000
Strike80.00
Expiry date2023-01-20
Day's range0.5500 - 0.5700
Contract rangeN/A
Volume9
Open interestN/A
  • Motley Fool

    3 Top Dividend Stocks for Generating Passive Income

    One great way to make passive income is to invest in dividend stocks. Here's why they selected AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Merck (NYSE: MRK). Keith Speights (AbbVie): Only the most elite dividend stocks become Dividend Kings.

  • Zacks

    Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates

    The FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and Novartis's (NVS) cancer combination drugs, Tafinlar (dabrafenib) + Mekinist (trametinib).

  • Motley Fool

    Got $1,000? Buy These 2 Ultra-High-Yield Dividend Stocks on the Dip

    As prices go down, yields go up, and that dynamic has made both Target (NYSE: TGT) and AbbVie (NYSE: ABBV) excellent choices for bargain-hunters searching for quality companies with yields well above the current 1.7% average of S&P 500 index stocks. For quite some time, Target was the retail stock that could do no wrong. The company repeatedly posted revenue growth and strong profitability, even through the pandemic, and there was little indication of serious trouble.